Injectable PRF
Preclinical
Injectable PRF is one of 2 therapeutic programs targeting Intrabony Periodontal Defects. It is currently in Preclinical.
1
Indications
2
Total Trials
1
Active Trials
1
Competitors
Pipeline
Status by Indication[2][1]
Indication
Competition
Competitive Landscape
1 competitor in Intrabony Periodontal Defects
#DrugCompanyPhaseTrials
1Amoxicillin/clavulanate Potassium
Johnson & JohnsonPreclinical
Injectable PRF
CCairo University
Preclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Expected Milestones
Clinical
Trials by Indication[1]
Sources
References
- [1]
- [2]Open Targets Platform — Drug–disease associations for Injectable PRF. EMBL-EBI & Wellcome Sanger Institute.
- [3]
Details
Drug Info
Quick Facts
- Highest Phase
- Preclinical[1]
- Company
- CCairo University